Newsletters & General

Dear Andrea, NEXT WEEK!  Goodfellow Symposium 2026 And while we wait, here are our latest webinars and podcasts:    Functional gastrointestinal conundrums: Utilising the MDT WEBINAR 17 March: The team from Allevia Hospitals will distil key practical tips and demonstrate how a team-based, multidisciplinary approach can help clinicians manage common GI conundrums more effectively.    Register here   Adult ADHD in practice: A clinical Q&A  WEBINAR 19 March: Join David Codyre for

Please see Research Review edition attached

Please see Research Review edition attached

Kia ora   The March 2026 edition of Prescriber Update  is now available on the Medsafe website. Please can you share it with your networks.   Kind regards   Medsafe Pharmacovigilance Team

Issue 337 - 5 March 2026 Welcome to the fortnightly Health Improvement and Innovation Digest. The Digest has links to key evidence of interest, with access to new content arranged by topic. You can forward this newsletter to others who may be interested in receiving it. They can register and subscribe here . You can also access other recent issues of the digest here. If you have any queries, please email us at  library@health.govt.nz . Article Access For articles that aren't

A randomized trial compared oral ivermectin with 5% permethrin for treating scabies in index cases and household clusters of up to eight people 1 . Ivermectin 200 µg/kg was taken with food on days 0 and 10, while permethrin was applied head-to-toe, including hair, genitalia, and children’s faces, left on overnight, and washed off after at least eight hours. Emollients and textile decontamination were advised. Children under 15 kg received permethrin only.  Cluster-level cur

Please see the AWHC Newsletter attached.

The Misuse of Drugs (Medicinal Cannabis) Regulations 2019 (the Regulations) set the minimum quality standard that medicinal cannabis products and ingredients must meet before they can be supplied in New Zealand. Importers, manufacturers, and suppliers must apply for assessment and provide evidence to the Medicinal Cannabis Agency to verify that their products meet the minimum quality standard. Sunrise T21.1 has been verified as meeting the minimum quality standard. More infor

Just over 3 weeks to go!  Goodfellow Symposium 2026 In the meantime, here are our latest webinars and podcasts:  Sexuality & Intimacy Workshop FACE-TO-FACE WORKSHOP in AUCKLAND 26 & 27 February: Join Allyson Waite for a 2-day workshop designed to extend your knowledge regarding sexuality and intimacy.   Register here   Whole of life protection: A focus on adult vaccination WEBINAR 3 March: Nikki Turner on the importance of adult immunisation as part of comprehensive preventi

Breakfast with a show! On both days of the Symposium, we'll serve breakfast alongside great talks. Your only challenge will be deciding which to go to.On Saturday morning you have a choice of: Winter readiness: Respiratory management essentials, with James Wethasinghe Moving our A into G for CKM health, with Walaa Saweirs Sunday's offering: Cardiovascular risk after COPD exacerbations in NZ and the role of triple therapy, with Jeff Harrison and William Good The 6th Anniversar

Welcome to the fortnightly Health Improvement and Innovation Digest. The Digest has links to key evidence of interest, with access to new content arranged by topic. You can forward this newsletter to others who may be interested in receiving it. They can register and subscribe here . You can also access other recent issues of the digest here. If you have any queries, please email us at  library@health.govt.nz Article Access For articles that aren't open access, contact your H

Kia ora ,The countdown is on to International Rare Disease Day on 28 February, which also marks the beginning of Rare Disorders Month - and we’re excited to see how you will Glow Up and Show Up for Rare  this March! We've made it super easy to join the campaign with our new fundraising platform. Simply sign up  to create your own fundraising page and decide how you would like to #GlowUpShowUp for rare. From morning teas to movie nights, or perhaps even a personal challenge -

Kia ora koutou, OUR LATEST TE WHATA KURA UPDATE – FEBRUARY 2026 We are pleased to share our latest Te Whata Kura newsletter, attached to this email. It includes updates on febrile neutropenia and maternal guidelines, as well as links to promotional and support materials.  You can access Te Whata Kura here:   https://tewhatakura.nz   Please share this newsletter widely across your networks, including clinicians, committees, organisations, and professional bodies involved with

The Misuse of Drugs (Medicinal Cannabis) Regulations 2019 (the Regulations) set the minimum quality standard that medicinal cannabis products and ingredients must meet before they can be supplied in New Zealand. Importers, manufacturers, and suppliers must apply for assessment and provide evidence to the Medicinal Cannabis Agency to verify that their products meet the minimum quality standard. KIKUYA Alta Oil [FS 10:10], has been verified as meeting the minimum quality standa

A systematic review in The Lancet 1  outlined the cardiometabolic issues with antidepressants.There were a few surprises: None had significant QT interval issues.  Systolic BP went up with amitriptyline and fluoxetine and down with nortriptyline.  Weight loss was observed with bupropion, sertraline, citalopram, paroxetine, and venlafaxine.  Weight gain was found with amitriptyline 1.6 kg and mirtazapine 0.87 kg. Heart rate increased (beats per minute) to 13.77 for nortriptyli

The Misuse of Drugs (Medicinal Cannabis) Regulations 2019 (the Regulations) set the minimum quality standard that medicinal cannabis products and ingredients must meet before they can be supplied in New Zealand. Importers, manufacturers, and suppliers must apply for assessment and provide evidence to the Medicinal Cannabis Agency to verify that their products meet the minimum quality standard. Aurora Half Moon has been verified as meeting the minimum quality standard. More in

Allevia Hospitals is one of New Zealand’s largest private surgical hospital providers, with leading medical specialists.  Here's their team for the Symposium, ready to provide you with thorough and timely updates across a wide range of topics – from understanding perimenopausal bleeding patterns, weight-loss medication, managing nasal symptoms, to diagnosing and treating Anterior Cutaneous Nerve Entrapment Syndrome (ACNES): Wal Baraza | Jacob Munro | Craig Ball | Nadya York |

Less than 8 weeks to go!  Goodfellow Symposium 2026 In the meantime, here are our latest webinars and podcasts:  Adult ADHD: From diagnosis to long-term management WEBINAR 3 February, 7.30pm: Join Psychiatrist David Codyre who will provide practical guidance on continuing ADHD care once treatment has begun.  Register here   Ovarian cancer: diagnosis to treatment WEBINAR 10 February, 7.30pm: Join Gynae-Oncologist Cecile Bergzoll on offering practical guidance to ovarian cancer

Te Whata Kura is the new national antimicrobial guideline. It includes revised guidance around: Cellulitis, irrespective of patient BMI, 1000mg Flucloxacillin QID with food for 5 days. Cystitis, uncomplicated: Nitrofurantoin (Micronised version trade name Macrobid), so as not to confuse with the regular Nitrofurantoin and underdose the patient (100 mg BD for 5 days with food). Adult unilateral otitis media and no severe symptoms no antibiotics needed. Adult bilateral otitis m

We're starting the year with a flurry of premium content for you, and if you're thinking about coming to the Goodfellow Symposium in March, today is the last day to nab a bargain:  Goodfellow Symposium 2026 Medical ethics PODCAST episode: Professor Angela Ballantyne discusses some commonly encountered medical ethics cases in general practice.  Episode here   Adult ADHD: From diagnosis to long-term management WEBINAR 3 February, 7.30pm: Join Psychiatrist David Codyre who will